Zealand Pharma A/S (ZLDPF)
OTCMKTS · Delayed Price · Currency is USD
61.06
+2.66 (4.55%)
Jul 24, 2025, 11:24 AM EDT

Zealand Pharma Company Description

Zealand Pharma A/S, a biotechnology company, engages in the discovery, development, and commercialization of peptide-based medicines in Denmark and the United States.

The company has a portfolio of medicines focusing on gastrointestinal and metabolic diseases, and other specialty disease areas with unmet medical needs.

It also provides Zegalogue, a single use syringe or autoinjector for the treatment of severe hypoglycemia; and Dasiglucagon bi-hormone artificial pancreas systems containing insulin and dasiglucagon.

Its pipeline includes Dasiglucagon for treating congenital hyperinsulinism. In addition, the company developing glepaglutide, a long acting GLP-2 analog, which is in Phase III clinical trials for the treatment of short bowel syndrome.

Zealand Pharma A/S was incorporated in 1997 and is based in Søborg, Denmark.

Zealand Pharma A/S
Zealand Pharma logo
CountryDenmark
Founded1997
IndustryBiotechnology
SectorHealthcare
Employees335
CEOAdam Steensberg

Contact Details

Address:
Sydmarken 11
Søborg, 2860
Denmark
Phone45 88 77 36 00
Websitezealandpharma.com

Stock Details

Ticker SymbolZLDPF
ExchangeOTCMKTS
Fiscal YearJanuary - December
Reporting CurrencyDKK
ISIN NumberDK0060257814
SIC Code2836

Key Executives

NamePosition
Adam Sinding Steensberg M.D.President and Chief Executive Officer
Henriette WennickeExecutive Vice President and Chief Financial Officer
Ivan Mourits MollerExecutive Vice President and Chief Operating Officer
Utpal SinghChief Scientific Officer
Ravinder Singh ChahilExecutive Vice President and General Counsel
Christina Sonnenborg BredalExecutive Vice President and Chief People Officer
Dr. Jens Damsgaard Mikkelsen M.D.Head of Molecular Pharmacology
Dr. David M. Kendall M.D.Executive Vice President, Chief Medical Officer and Head of Research & Development
Eric CoxExecutive Vice President and Chief Commercial Officer
Steven B. Johnson Pharm.D.Chief Development Officer